Many biological assays use antibodies to detect SRC, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with SRC in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop SRC antibodies...
We validate the specificity of these antibodies to SRC by testing them on tissues known to express SRC positively and negatively. Browse below to find the SRC antibody that suites your experiment. We have 94 of these antibodies and many publications and validation images.
If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.
Facts about Proto-oncogene tyrosine-protein kinase Src.
Proto-oncogene tyrosine-protein kinase Src (SRC)
Non-receptor protein tyrosine kinase that is activated following engagement of many different classes of cellular receptors including immune response receptors, integrins and other adhesion receptors, receptor protein tyrosine kinases, G protein- coupled receptors as well as cytokine receptors. Due to functional redundancy between members of the SRC kinase family, identification of the specific role of each SRC kinase is very difficult.
SRC appears to be among the principal kinases activated following engagement of receptors and plays a role in the activation of other protein tyrosine kinase (PTK) families. Receptor clustering or dimerization leads to recruitment of SRC to the receptor complexes in which it phosphorylates the tyrosine residues within the receptor cytoplasmic domains.
Expressed ubiquitously. Platelets, neurons and osteoclasts express 5-fold to 200-fold higher levels than most other tissues.
Subcellular Localizations
Cell membrane; Lipid-anchor. Mitochondrion inner membrane. Nucleus. Cytoplasm, cytoskeleton. Cytoplasm, perinuclear region. Cell junction, focal adhesion. Localizes to focal adhesion sites following integrin engagement (PubMed:22801373). Localization to focal adhesion sites requires myristoylation and the SH3 domain (PubMed:7525268). Colocalizes with PDLIM4 at the perinuclear region, but not at focal adhesions (PubMed:19307596).
Diseases
Malignant Neoplasms
Neoplasms
Tissue Adhesions
Cell Transformation, Neoplastic
Sarcoma
Neoplasm Metastasis
Carcinoma
Cell Invasion
Leukemia
Malignant Neoplasm Of Breast
Mammary Neoplasms
Tumor Angiogenesis
Malignant Paraganglionic Neoplasm
Inflammation
Neoplasm Invasiveness
Metaplastic Cell Transformation
Myeloid Leukemia
Adenocarcinoma
Pathways
Cell Proliferation
Localization
Cell Migration
Cell Growth
Cell Adhesion
Cell Cycle
Angiogenesis
Secretion
Endocytosis
Pathogenesis
Cell Activation
Cell Death
Cell Motility
Transport
T Cell Activation
Rna Interference
Translation
Immune Response
Chemotaxis
Cell Differentiation
PTMs
Phosphorylation
Dephosphorylation
Cleavage
Myristoylation
Ubiquitination
Methylation
Palmitoylation
Reduction
Acetylation
Oxidation
Biotinylation
Acylation
Glycosylation
Ribosylation
Nitration
Prenylation
Nitrosylation
Farnesylation
Demethylation
Amidation
For details, visit: bosterbio.com/bosterbio-gene-info-cards/SRC
References
PMID: 3299057 by Tanaka A., et al. DNA sequence encoding the amino-terminal region of the human c-src protein: implications of sequence divergence among src-type kinase oncogenes.
PMID: 2582238 by Anderson S.K., et al. Human cellular src gene: nucleotide sequence and derived amino acid sequence of the region coding for the carboxy-terminal two-thirds of pp60c-src.
8 Publications of Boster SRC Antibodies & ELISA Kits
PubMed ID: 10.3748/wjg.v24.i22.2381, Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase be...
PubMed ID: 10.2147/DDDT.S265198, Integrated Network Pharmacology Analysis and Experimental Validation to Reveal t...